As #ASH24 wraps up, we’re proud of the impactful work shared by Moffitt experts, from novel therapies to overcoming treatment resistance. Together, we’re advancing the fight against blood cancers!🩸#MoffittASH24

Faustine Ong, MD (Faustine_Ong) joins us to discuss disparities in AML survival in the targeted therapy era. Read more 👉 bit.ly/41l5NGE ASH #MoffittASH24

At #ASH24, Ziad Abuhelwa, MD (@zabuhelwa) shares the progression patterns and outcomes in multiple myeloma after anti-BCMA CAR T-cell therapy. Read more 👉 bit.ly/3ZJjbU4 ASH #MoffittASH24

Nelli Bejanyan, MD joins us to share the findings of a first-in-human trial using expanded donor gamma delta T cell immunotherapy to prevent acute myeloid leukemia relapse after allogeneic transplantation. Read more 👉 bit.ly/3D1kLYq ASH #MoffittASH24

At #ASH24, Jeremy DiGennaro, DO (@JeremyDigennaro) discusses post-approval utilization of pacritinib and momelotinib in patients with myelofibrosis and an analysis of early treatment outcomes. #MoffittASH24

At #ASH24, David Sallman, MD joins us to discuss a prospective evaluation of the impact of measurable residual disease by error-corrected next-generation sequencing with CPX-351 in acute myeloid leukemia. Read more 👉 bit.ly/41E3Wgz ASH #MoffittASH24

At #ASH24, Bijal Shah, MD discusses the healthcare resource utilization and costs associated with managing CRS and ICANS in patients with relapsed /refractory adult B-cell acute lymphoblastic leukemia receiving obecabtagene autoleucel. Read more 👉bit.ly/3B5cbr3

While at #ASH24, Praneeth Reddy Sudalagunta, PhD shared the differential effects of bridging therapy on the immune microenvironment and outcomes with idecabtagene-vicleucel in multiple myeloma. Read more 👉 bit.ly/3Zlw8lj ASH #MoffittASH24

Ziad Abuhelwa, MD (@zabuhelwa) joined us at #ASH24 to discuss a retrospective analysis of the outcomes of a large cohort of MDS patients to compare outcomes between IDH1-MT and wild-type. Read more 👉 bit.ly/41n9c7P ASH #MoffittASH24

Meet Karen Lu, MD (Karen Lu) who joined Moffitt in June 2024 as the physician in chief. She is a nationally recognized physician-scientist who specializes in advancing care for women with ovarian and endometrial cancers. Learn more: bit.ly/4gjmAhx

This summer, Moffitt McKinley Hospital celebrated its first year of serving patients. Team members have embraced the Moffitt culture, offering smiles, support and care to all. Discover their impactful moments from the past year: bit.ly/49l5Kwq

Dr. Karen Lu (@KarenLuMD) recently celebrated six months as Physician-in-Chief Moffitt Cancer Center! It's been a pleasure working alongside her. In this video, we talk about her journey, vision for the future, and what excites her most about Moffitt.

From pioneering FDA approved therapies to innovative predictive models, Moffitt redefined what was possible in cancer care this year Explore how our discoveries in 2024 are changing lives: bit.ly/4gzjplW

Reflecting on the groundbreaking research of 2024 Moffitt Cancer Center! From innovative treatments to breakthrough discoveries, we continue to push boundaries in cancer care. Excited for what’s to come in 2025. 🎉 moffitt.org/endeavor/archi…

As we welcome 2025, we are celebrating the unforgettable Moffitt moments of 2024, from research breakthroughs to patient care milestones. 💙 Read more: bit.ly/3ZJDAa9 Wishing you a happy New Year! 🎉

An exciting year at Moffitt!

From pioneering FDA approved therapies to expanding access, Moffitt is redefining what is possible in cancer care. See how our discoveries in 2024 are changing lives: bit.ly/4gzjplW

Kick off the new year with this healthy and delicious recipe! Join Sylvia Crowder, PhD, (Sylvia Crowder) as she shares how to make salmon with yogurt avocado sauce.

We’re thrilled to announce the grand opening of Moffitt at SouthShore in south Hillsborough County this week! This new location brings cutting-edge technology, world-class cancer experts and comprehensive services like screenings, imaging, labs, oncology clinics, radiation

I’m excited to support Dr. Mikkael Sekeres for ASH Councillor! Mikkael A. Sekeres MD, MS has an incredible history of service to ASH, not to mention as a world expert in AML/MDS clinical research. As a leader, Mikkael has mastered the art of LISTENING to what people say and need and then